• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环状 RNA ECE1 通过海绵吸附 miR-588 调控 RAB3D 促进骨肉瘤进展。

CircECE1 promotes osteosarcoma progression through regulating RAB3D by sponging miR-588.

机构信息

Department of Bone and Soft Tissue Oncology, Shanxi Province Cancer Hospital, Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences, Cancer Hospital Affiliated to Shanxi Medical University, No.3, Zhigong New Street, Xinghualing District, Taiyuan, 030013, China.

出版信息

J Orthop Surg Res. 2023 Aug 9;18(1):587. doi: 10.1186/s13018-023-04045-4.

DOI:10.1186/s13018-023-04045-4
PMID:37559140
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10410784/
Abstract

BACKGROUND

Circular RNAs (circRNAs) have been confirmed to be involved in cancer pathogenesis. However, the underlying mechanism of circRNA endothelin converting enzyme 1 (circECE1) in osteosarcoma (OS) development is still not understood.

METHODS

The expression levels of circECE1, microRNA-588 (miR-588) and RAB3D, member RAS oncogene family (RAB3D) were gauged by quantitative real-time polymerase chain reaction (qRT-PCR) and western blot. OS cell proliferation was assessed by cell counting kit-8 (CCK-8) assay and 5-ethynyl-2'-deoxyuridine (EdU) assay. OS cell apoptosis rate and metastasis were identified by flow cytometry and transwell assay. Dual-luciferase reporter analysis and RNA immunoprecipitation (RIP) assay were performed to confirm the interactions among circECE1, miR-588 and RAB3D. Xenograft tumor models were established to explore circECE1 function in vivo. Immunohistochemistry (IHC) assay was applied to analyze RAB3D level after circECE1 knockdown.

RESULTS

In OS, circECE1 expression was higher than that in normal chondroma tissues. High levels of circECE1 were positively linked to OS cell viability, proliferation, migration and invasion, and negatively linked to OS cell apoptosis rate. It was found that circECE1 was a miR-588 sponge, and miR-588 inhibitor abrogated the influence of si-circECE1 on OS cells. MiR-588 targeted RAB3D to further regulate the pathological process of OS. Moreover, silencing circECE1 blocked OS tumor growth in vivo.

CONCLUSION

We elucidated the function of a novel circECE1/miR-588/RAB3D axis in OS progression.

摘要

背景

环状 RNA(circRNAs)已被证实参与癌症的发病机制。然而,circRNA 内皮素转换酶 1(circECE1)在骨肉瘤(OS)发展中的潜在机制尚不清楚。

方法

通过实时定量聚合酶链反应(qRT-PCR)和 Western blot 测定 circECE1、microRNA-588(miR-588)和 RAS 癌基因家族成员 RAB3D(RAB3D)的表达水平。通过细胞计数试剂盒-8(CCK-8)测定和 5-乙炔基-2'-脱氧尿苷(EdU)测定评估 OS 细胞增殖。通过流式细胞术和 Transwell 测定鉴定 OS 细胞凋亡率和转移。通过双荧光素酶报告分析和 RNA 免疫沉淀(RIP)分析证实 circECE1、miR-588 和 RAB3D 之间的相互作用。建立异种移植肿瘤模型以研究 circECE1 在体内的功能。免疫组织化学(IHC)测定用于分析 circECE1 敲低后 RAB3D 的水平。

结果

在 OS 中,circECE1 的表达高于正常软骨瘤组织。高水平的 circECE1 与 OS 细胞活力、增殖、迁移和侵袭呈正相关,与 OS 细胞凋亡率呈负相关。发现 circECE1 是 miR-588 的海绵体,miR-588 抑制剂消除了 si-circECE1 对 OS 细胞的影响。miR-588 靶向 RAB3D 以进一步调节 OS 的病理过程。此外,沉默 circECE1 阻断了 OS 肿瘤在体内的生长。

结论

我们阐明了新型 circECE1/miR-588/RAB3D 轴在 OS 进展中的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/71dd79a9faa9/13018_2023_4045_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/41beffa7b505/13018_2023_4045_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/ceab4287de04/13018_2023_4045_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/0a987f554783/13018_2023_4045_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/6bb3c646a89d/13018_2023_4045_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/2618d22da371/13018_2023_4045_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/5d5468372c82/13018_2023_4045_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/0c5827a0ad18/13018_2023_4045_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/71dd79a9faa9/13018_2023_4045_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/41beffa7b505/13018_2023_4045_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/ceab4287de04/13018_2023_4045_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/0a987f554783/13018_2023_4045_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/6bb3c646a89d/13018_2023_4045_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/2618d22da371/13018_2023_4045_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/5d5468372c82/13018_2023_4045_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/0c5827a0ad18/13018_2023_4045_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ded/10410784/71dd79a9faa9/13018_2023_4045_Fig8_HTML.jpg

相似文献

1
CircECE1 promotes osteosarcoma progression through regulating RAB3D by sponging miR-588.环状 RNA ECE1 通过海绵吸附 miR-588 调控 RAB3D 促进骨肉瘤进展。
J Orthop Surg Res. 2023 Aug 9;18(1):587. doi: 10.1186/s13018-023-04045-4.
2
CircRNA PRH1-PRR4 stimulates RAB3D to regulate the malignant progression of NSCLC by sponging miR-877-5p.环状 RNA PRH1-PRR4 通过海绵吸附 miR-877-5p 来刺激 RAB3D 调控 NSCLC 的恶性进展。
Thorac Cancer. 2022 Mar;13(5):690-701. doi: 10.1111/1759-7714.14264. Epub 2022 Jan 25.
3
CircECE1 activates energy metabolism in osteosarcoma by stabilizing c-Myc.环状 RNA ECE1 通过稳定 c-Myc 激活骨肉瘤中的能量代谢。
Mol Cancer. 2020 Oct 26;19(1):151. doi: 10.1186/s12943-020-01269-4.
4
Silencing circular RNA hsa_circABCC1 inhibits osteosarcoma progression through down-regulating HDAC4 via sponging miR-591.沉默环状 RNA hsa_circABCC1 通过海绵吸附 miR-591 下调 HDAC4 抑制骨肉瘤进展。
Environ Toxicol. 2023 Jul;38(7):1565-1576. doi: 10.1002/tox.23786. Epub 2023 Apr 13.
5
Down-regulation of circITCH promotes osteosarcoma development and resistance to doxorubicin via the miR-524/RASSF6 axis.环状 RNA ITCH 通过 miR-524/RASSF6 轴下调促进骨肉瘤的发展和对阿霉素的耐药性。
J Gene Med. 2021 Oct;23(10):e3373. doi: 10.1002/jgm.3373. Epub 2021 Jul 20.
6
Long non-coding RNA FGD5-AS1 enhances osteosarcoma cell proliferation and migration by targeting miR-506-3p/RAB3D axis.长链非编码 RNA FGD5-AS1 通过靶向 miR-506-3p/RAB3D 轴增强骨肉瘤细胞的增殖和迁移。
Hum Cell. 2021 Jul;34(4):1255-1265. doi: 10.1007/s13577-021-00536-w. Epub 2021 Apr 23.
7
Silencing of circ-CDK14 suppresses osteosarcoma progression through the miR-198/E2F2 axis.环状CDK14的沉默通过miR-198/E2F2轴抑制骨肉瘤进展。
Exp Cell Res. 2022 May 1;414(1):113082. doi: 10.1016/j.yexcr.2022.113082. Epub 2022 Feb 23.
8
Hsa_circ_0103232 promotes melanoma cells proliferation and invasion via targeting miR-661/RAB3D.Hsa_circ_0103232 通过靶向 miR-661/RAB3D 促进黑色素瘤细胞的增殖和侵袭。
Cell Cycle. 2022 Sep;21(17):1811-1826. doi: 10.1080/15384101.2022.2072636. Epub 2022 May 13.
9
[miR-125b-5p inhibits proliferation and migration of osteosarcoma cells by negatively regulating RAB3D expression].[微小RNA-125b-5p通过负向调控RAB3D表达抑制骨肉瘤细胞的增殖和迁移]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jan 20;43(1):68-75. doi: 10.12122/j.issn.1673-4254.2023.01.09.
10
Circular RNA circ_UBAP2 facilitates the progression of osteosarcoma by regulating microRNA miR-637/high-mobility group box (HMGB) 2 axis.环状 RNA circ_UBAP2 通过调控 microRNA miR-637/高迁移率族蛋白(HMGB)2 轴促进骨肉瘤的进展。
Bioengineered. 2022 Feb;13(2):4411-4427. doi: 10.1080/21655979.2022.2033447.

引用本文的文献

1
Rab3B Proteins: Cellular Functions, Regulatory Mechanisms, and Potential as a Cancer Therapy Target.Rab3B蛋白:细胞功能、调控机制及其作为癌症治疗靶点的潜力
Cell Biochem Biophys. 2025 Mar;83(1):263-277. doi: 10.1007/s12013-024-01549-6. Epub 2024 Sep 25.
2
Osteosarcoma in a ceRNET perspective.中枢神经系统外尤文肉瘤的临床特征。
J Biomed Sci. 2024 Jun 5;31(1):59. doi: 10.1186/s12929-024-01049-y.

本文引用的文献

1
Small interfering RNAs in the management of human rheumatoid arthritis.小干扰 RNA 在人类类风湿性关节炎治疗中的应用。
Br Med Bull. 2022 Jul 9;142(1):34-43. doi: 10.1093/bmb/ldac012.
2
Research Progress of Exosome-Loaded miRNA in Osteosarcoma.外泌体负载 miRNA 在骨肉瘤中的研究进展。
Cancer Control. 2022 Jan-Dec;29:10732748221076683. doi: 10.1177/10732748221076683.
3
Circular RNA circ_0089153 acts as a competing endogenous RNA to regulate colorectal cancer development by the miR-198/SUMO-specific peptidase 1 (SENP1) axis.
环状 RNA circ_0089153 通过 miR-198/SUMO 特异性肽酶 1 (SENP1) 轴作为竞争性内源性 RNA 调节结直肠癌的发展。
Bioengineered. 2021 Dec;12(1):5664-5678. doi: 10.1080/21655979.2021.1967076.
4
Hsa_circ_0004712 downregulation attenuates ovarian cancer malignant development by targeting the miR-331-3p/FZD4 pathway.Hsa_circ_0004712 的下调通过靶向 miR-331-3p/FZD4 通路抑制卵巢癌恶性进展。
J Ovarian Res. 2021 Sep 10;14(1):118. doi: 10.1186/s13048-021-00859-0.
5
Circular RNA circVRK1 suppresses the proliferation, migration and invasion of osteosarcoma cells by regulating zinc finger protein ZNF652 expression via microRNA miR-337-3p.环状 RNA circVRK1 通过调控锌指蛋白 ZNF652 表达的微小 RNA miR-337-3p 抑制骨肉瘤细胞的增殖、迁移和侵袭。
Bioengineered. 2021 Dec;12(1):5411-5427. doi: 10.1080/21655979.2021.1965695.
6
circRNA hsa_circ_0005909 Predicts Poor Prognosis and Promotes the Growth, Metastasis, and Drug Resistance of Non-Small-Cell Lung Cancer via the miRNA-338-3p/SOX4 Pathway.环状 RNA hsa_circ_0005909 通过 miRNA-338-3p/SOX4 通路预测非小细胞肺癌的不良预后,并促进其生长、转移和耐药性。
Dis Markers. 2021 Aug 6;2021:8388512. doi: 10.1155/2021/8388512. eCollection 2021.
7
CircRAB3IP upregulates twist family BHLH transcription factor (TWIST1) to promote osteosarcoma progression by sponging miR-580-3p.环状 RNA 结合蛋白 3 相互作用蛋白通过海绵吸附 miR-580-3p 上调 TWIST 家族碱性螺旋-环-螺旋转录因子 1(TWIST1)促进骨肉瘤进展。
Bioengineered. 2021 Dec;12(1):3385-3397. doi: 10.1080/21655979.2021.1948487.
8
Circular RNA circ-CHI3L1.2 modulates cisplatin resistance of osteosarcoma cells via the miR-340-5p/LPAATβ axis.环状RNA circ-CHI3L1.2通过miR-340-5p/LPAATβ轴调节骨肉瘤细胞的顺铂耐药性。
Hum Cell. 2021 Sep;34(5):1558-1568. doi: 10.1007/s13577-021-00564-6. Epub 2021 Jun 23.
9
Downregulation of miR-588 is associated with tumor progression and unfavorable prognosis in patients with osteosarcoma.miR-588的下调与骨肉瘤患者的肿瘤进展和不良预后相关。
Exp Ther Med. 2021 Jun;21(6):592. doi: 10.3892/etm.2021.10024. Epub 2021 Apr 8.
10
Small interfering RNAs in tendon homeostasis.小干扰 RNA 在肌腱稳态中的作用。
Br Med Bull. 2021 Jun 10;138(1):58-67. doi: 10.1093/bmb/ldaa040.